Trials / Completed
CompletedNCT03016052
Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Anxiety
Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Social and Generalized Anxiety- an ERP Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Tel Aviv University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
this study examines the emergence of the visual mismatch negativity (vMMN) ERP component in response to deviations from the embedded contingency in attention bias modification treatment (ABMT) for social and generalized anxiety, and the interaction between vMMN emergence and clinical improvement. \*\*\*As of September 2017, recruitment of SAD participants has concluded.
Detailed description
all participants, suffering from either social anxiety disorder or generalized anxiety disorder, will receive 6 sessions of ABMT, adapted for an oddball paradigm. two of the sessions will also include simultaneous EEG measurement. the goal of the study is to determine the emergence of vMMN in response to trials deviating the embedded contingency and to examine the correlation between vMMN emergence and clinical improvement of anxiety symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | ABMT | Participants will be trained with a dot-probe task including angry-neutral faces. The task will be adapted for the oddball paradigm, such that in 80% of trials the probe will appear in place of the neutral face, and in 20% of trials in place of the angry face. |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-09-01
- Completion
- 2017-10-01
- First posted
- 2017-01-10
- Last updated
- 2017-11-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03016052. Inclusion in this directory is not an endorsement.